Research Topics
| A BerringtonSummaryAffiliation: Cancer Research UK Country: UK Publications
| Collaborators
|
Detail Information
Publications
Additive and multiplicative models for the joint effect of two risk factorsA Berrington de Gonzalez
Cancer Research UK Epidemiology Unit, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford, OX2 6HE, UK
Biostatistics 6:1-9. 2005..Because of the simple form of the test statistics, combination of evidence from different studies or strata is straightforward. Illustration of how the method could be extended to data from a 2xRxC table is also given...
Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysisA Berrington de Gonzalez
Cancer Research UK Epidemiology Unit, Gibson Building, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
Br J Cancer 90:1787-91. 2004..Further evidence is needed to confirm this in view of the limited data available...
A meta-analysis of obesity and the risk of pancreatic cancerA Berrington de Gonzalez
Cancer Research UK Epidemiology Unit, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford OX2 6HE, UK
Br J Cancer 89:519-23. 2003..These results provide evidence that the risk of pancreatic cancer may be weakly associated with obesity. However, the small magnitude of the summary risk means the possibility of confounding cannot be excluded...
Generalized least squares for the synthesis of correlated informationA Berrington
Cancer Research UK Epidemiology Unit, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford, OX2 6HE, UK
Biostatistics 4:423-31. 2003..We then illustrate the method with several examples from an analysis in which case-control studies of cervical cancer and oral contraceptive use are synthesized...
Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countriesAmy Berrington de Gonzalez
Cancer Research UK Epidemiology Unit, University of Oxford, Radcliffe Infirmary, Oxford, UK
Lancet 363:345-51. 2004..Our aim was to estimate the extent of this risk on the basis of the annual number of diagnostic X-rays undertaken in the UK and in 14 other developed countries...
N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interactionJ Green
Imperial Cancer Research Fund Cancer Epidemiology Unit, University of Oxford, Radcliffe Infirmary, UK
Br J Cancer 83:412-7. 2000..Even if estimates of the effect of NAT2 from published data are correct, studies with around 3000-5000 cases will be needed to confirm them...
Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical CancerJ Green
Cancer Research UK Epidemiology Unit, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford OX2 6HE, UK
Br J Cancer 89:2078-86. 2003..Further studies are needed to confirm the suggestion from this and other studies of differences in risk related to smoking between squamous cell and adenocarcinomas of the cervix...
Human papillomavirus infection and use of oral contraceptivesJ Green
Cancer Research UK Epidemiology Unit, University of Oxford, Gibson Building, Radcliffe Infirmary, UK
Br J Cancer 88:1713-20. 2003..Further studies are needed to confirm these findings and to investigate possible relations between oral contraceptive use and the persistence and detectability of cervical HPV infection...
100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997A Berrington
Imperial Cancer Research Fund, Cancer Epidemiology Unit, Radcliffe Infirmary, Oxford OX2 6HE, UK
Br J Radiol 74:507-19. 2001....
Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefitsA Berrington de Gonzalez
Cancer Research UK Epidemiology Unit, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford OX2 6HE, UK
Br J Cancer 93:590-6. 2005..Although these calculations were based on a number of uncertain parameters, in general, the conclusions were not altered when these parameters were varied within a feasible range...
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controlsV Beral
Cancer Epidemiology Unit, Oxford, UK
Lancet 371:303-14. 2008..Oral contraceptives can reduce the risk of ovarian cancer, but the eventual public-health effects of this reduction will depend on how long the protection lasts after use ceases. We aimed to assess these effects...
